Critically Ill Older Adults' Representation in Intervention Trials: A Systematic Review.


Journal

Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

Older adults may be under-represented in critical care research, and results may not apply to this specific population. Our primary objective was to evaluate the prevalence of inclusion of older adults across critical care trials focused on common ICU conditions or interventions. Our secondary objective was to evaluate whether older age was used as a stratification variable for randomization or outcome analysis. We performed a systematic review of previously published systematic reviews of randomized controlled trials (RCTs) in critical care. We searched PubMed, Ovid, CENTRAL, and Cochrane from 2009 to 2022. Systematic reviews of any interventions across five topics: acute respiratory distress syndrome (ARDS), sepsis/shock, nutrition, sedation, and mobilization were eligible. We identified 216 systematic reviews and included a total of 253 RCTs and 113,090 patients. We extracted baseline characteristics and the reported proportion of older adults. We assessed whether any upper age limit was an exclusion criterion for trials, whether age was used for stratification during randomization or data analysis, and if age-specific subgroup analysis was present. The most prevalent topic was sepsis (78 trials, 31%), followed by nutrition (62 trials, 25%), ARDS (39 trials, 15%), mobilization (38 trials, 15%), and sedation (36 trials, 14%). Eighteen trials (7%) had exclusion criteria based on older age. Age distribution with information on older adults prevalence was given in six trials (2%). Age was considered in the analysis of ten trials (5%) using analytic methods to evaluate the outcome stratified by age. In this systematic review, the proportion of older critically ill patients is undetermined, and it is unclear how age is or is not an effect modifier or to what extent the results are valid for older adult groups. Reporting age is important to guide clinicians in personalizing care. These results highlight the importance of incorporating older critically ill patients in future trials to ensure the results are generalizable to this growing population.

Identifiants

pubmed: 38919511
doi: 10.1097/CCE.0000000000001107
pii: CCE-D-22-00496
pmc: PMC11196082
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1107

Informations de copyright

Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.

Déclaration de conflit d'intérêts

The authors have disclosed that they do not have any potential conflicts of interest.

Auteurs

Marie-France Forget (MF)

Department of Medicine, Division of Geriatric Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Han Ting Wang (HT)

Department of Medicine, Division of Critical Care Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Raphaelle Carignan (R)

Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Alexandre Dessureault (A)

Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Mathieu Gravel (M)

Department of Medicine, Faculty of Medicine, Université de Laval, Québec, QC, Canada.

Jeanne Bienvenue (J)

Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Maude Bouchard (M)

Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Camille Durivage (C)

Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.

Richard Coveney (R)

Teaching Division/Library, Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est-de-l'île-de-Montréal, Montréal, QC, Canada.

Laveena Munshi (L)

Interdepartmental Division of Critical Care, Sinai Health System, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH